StockData
Bioventus Inc. logo

Bioventus Inc. (BVS) balance sheet

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3036% below fair value
$9.88−0.07 (-0.70%)

Close on Nov 20, 2026Market cap $830.83MP/E 12.8Yield –

Bioventus Inc. balance sheet

Ratios

Latest available, balances at Jun 27, 2026

Profitability, TTM

Gross margin
68.7%
Operating margin
10.0%
Net margin
9.4%
Return on equity, FY2025
13.7%

Financial strength

Current ratio
1.69
Debt to equity
1.09
Debt to assets
36.9%
Cash to current liabilities
19.3%

Valuation

P/E ratio
12.8
Price to sales
1.43
Price to book
3.64
Dividend yield
–

See a number that looks wrong?